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Characteristics and Outcome of Patients With Dual Pulmonary 
Tuberculosis and Non-mycobacterial Respiratory Infections
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Abstract
Background: Mixed tuberculosis (TB) and bacterial respiratory 
infections are usually seen in areas where there is an HIV epi-
demic. However, there have been no previous reports regarding 
TB patients with concomitant bacterial respiratory infections in a 
non-HIV prevalent region. This study was to evaluate the clinical 
characteristics and outcomes of patients with dual TB and bacterial 
respiratory infections in Hualien, Taiwan.
Methods: A retrospective cohort study was conducted in a com-
munity teaching hospital in Hualien from 2000 to 2007. Those who 
fulﬁ  lled the criteria for active pulmonary tuberculosis (PTB) were 
included and divided into subjects with concomitant bacterial in-
fections and controls. Their basic data, clinical presentations and 
in-hospital outcomes were reviewed and analyzed.
Results: During 2000 - 2007, a total of 182 patients were diagnosed 
as having PTB. Of them, 54 (29.7%) had dual infections. Comor-
bidities were common in these patients. Older age and lower socio-
economic status were present in subjects than in controls. In terms 
of disease characteristics, symptoms of cough and sputum produc-
tion, laboratory ﬁ  ndings of leukocytosis with left shift, thrombo-
cytopenia, renal insufﬁ  ciency and lower serum albumin level, as 
well as radiographic patterns of multi-lobar inﬁ  ltrates and alveolar 
consolidations prevailed amongst subjects (P < 0.05). Delayed di-
agnosis in PTB and increased rates of in-hospital morbidity and 
mortality associated with polymicrobial infections were noted in 
subjects with dual infections.
Conclusions: In a non-HIV prevalent area, patients of older age, 
lacking access to good health care, and suffering from malnutrition 
were predisposed to dual infections and had poor prognosis and 
outcomes.
Keywords: Pulmonary tuberculosis; Dual nontuberculous bacterial 
respiratory infections
Introduction
Tuberculosis (TB) has been emphasized as a worldwide con-
tagious infectious disease since the emergence of multidrug-
resistant strains, an increasing population of human immu-
nodeﬁ  ciency virus (HIV) co-infection, and most importantly, 
a lack of public health surveillance system for TB control in 
developing countries. According to the World Health Orga-
nization’s (WHO) annual estimations, the majority of new 
TB cases are concentrated in South-East Asia, Africa and 
Western Paciﬁ  c regions. In 2005, 1.6 million people died of 
TB, and an additional 200 000 deaths resulted from HIV-
associated TB [1].
Taiwan, located in the Western Paciﬁ  c region, is one of 
the TB epidemic areas in the world. Among Taiwan’s twen-
ty-three counties and municipalities, Hualien was the leading 
TB prevalent community, where the rate of incidence aver-
aged 120.0 per 100 000 populations over the past decade [2]. 
In this community, patients with poor medical compliance, 
low socioeconomic conditions, and alcoholism were the 
main contributors to new cases of this disease, rather than 
those with HIV. As a member of the global village, Taiwan’s 
government has advanced a policy intending to halve the 
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prevalence and mortality rates of TB within ten years, which 
corresponds to the targets of the “Global Plan to Stop TB 
2006 - 2015” launched by WHO [3].
To date, there has been a number of research projects 
conducted in HIV-dense region to discover the poor prog-
nosis of tuberculous patients coexisting with HIV [4, 5], es-
pecially those with other microbial infections [6]. However, 
the clinical outcome of pulmonary TB (PTB) and concur-
rent bacterial infections has rarely been demonstrated in a 
non-HIV associated TB-prevalent area. To our knowledge, 
mycobacterial antigens promote expression of inhibitory cy-
tokines and further depress response of T-helper cells, which 
results in immunosuppresion, deactivation of macrophage, 
and disease progression [7, 8]. Not only does reduced host 
immunity expose the tuberculous patient to opportunistic 
microbial infections, but poor living conditions does so as 
well. We hypothesize that both the functions of immunity 
and environmental factors, other than HIV, will determine 
the fate of patients with concomitant PTB and bacterial in-
fections. The aim of our study is to investigate the clinical 
characteristics and in-hospital outcomes of patients with 
dual active PTB and community-acquired non-mycobacteri-
al respiratory infections in Hualien, Taiwan.
Materials and Methods
Study subjects
The retrospective cohort study was conducted in Hualien 
Armed Forces General Hospital, a 400-bed community 
teaching hospital in eastern Taiwan. The hospitalized patients 
are mainly composed of military staff, conscripts and their 
families, veterans, inhabitants of the geriatric facility as well 
as civilians. Every patient admitted to our pulmonary section 
on the impression of respiratory tract infections will receive 
a thorough history taking and physical examinations. Chest 
roentgenogram, laboratory tests for whole blood cells, and 
biochemistries were obtained on admission. Routine screen 
of sputum or pleural ﬂ  uid cultures for bacteria and Myco-
bacterium tuberculosis and serologic tests for atypical patho-
gens were carried out after admission. Pleural biopsy and 
PTB-polymerase chain reaction would be done simultane-
ously with cultures if PTB was highly suspected. New cases 
of active PTB could be diagnosed about 30 - 40 persons per 
year in this hospital. We searched the mycobacterial report-
ing databases from January 2000 to December 2007. Those 
who fulﬁ  lled the criteria for active PTB were included and 
divided into subjects with dual bacterial infections and con-
trols with isolated TB infection. The following data was re-
viewed and analyzed from the medical records: demographic 
characteristics (age, sex, race, origin), socioeconomic status, 
comorbidities, symptoms, radiological appearance, bacterio-
logical investigation, laboratory investigations (total blood 
cell count, liver and renal function parameters, and fasting 
lipid proﬁ  les), HIV status, time lag for diagnosis of PTB and 
in-hospital outcomes (nosocomial pneumonia, respiratory 
failure, septic shock and mortality). The Tri-Service General 
Hospital Institutional Review Board approved the study and 
waived the requirement for informed consent for this retro-
spective review of medical records (TSGHIRB09705060).
Deﬁ  nitions
Active PTB was deﬁ  ned, according to the American Thorac-
ic Society classiﬁ  cation, that individuals testing positive for 
the Tuberculin Skin Test displayed clinical as well as radio-
graphic and/or microbiological evidence of Mycobacterium 
tuberculosis and suffered from PTB at the time of sampling 
[9]. Community-acquired non-mycobacterial respiratory 
infections present features of respiratory tract infection or 
appearance of a consolidation or inﬁ  ltrations in the chest 
radiograph that was consistent with acute infection. Micro-
biological studies uncovered the non-mycobacterial species 
from cultures of sputum/pleural ﬂ  uid or positive serologic 
antibody and urinary antigen tests on admission [10]. Cri-
teria for deﬁ  nite diagnosis of bacterial respiratory infection 
was made as followed: 1. The culture-conﬁ  rmed bacteria 
came from both sputum and the sterile sites including blood, 
pleural ﬂ  uid and bronchial tract secretions via bronchoal-
veolar lavage; 2. Patients who had negative acid-fast stains 
(AFB) without anti-tuberculous treatment responded well to 
the prescribed antibiotics within one week; 3. Patients with 
positive acid-fast stain or mixed bacterial infections were 
excluded. Low socioeconomic status was judged by the pa-
tient’s educational attainment (less than a high school de-
gree), poverty (deﬁ  nition by a family’s total income was less 
than the family’s threshold), or unemployment [11]. Renal 
insufﬁ  ciency involved a serum blood urea nitrogen (BUN)/
creatinine ratio > 20, a creatinine level > 2.0 mg/dL or a 
24-hour urinary creatinine clearance rate < 60 mL/minute. 
Delayed diagnosis of PTB referred to either initially missed 
diagnosis of PTB within the ﬁ  rst 24 hour after admission 
mostly owing to absence of associated symptoms, atypical 
radiographic presentations and unavailable laboratory evi-
dence for TB or delayed antituberculous treatment until 7 
days or more if all AFB were negative [12].
Microbiological studies
Routine microbiological evaluations contained the follow-
ing tests: two samples for blood aerobic and anaerobic con-
ventional cultures if the patient was febrile on admission; 
respiratory tract secretions or pleural ﬂ  uid were utilized for 
Gram stain/bacterial cultures at once and AFB/mycobacte-
rial cultures for three consecutive days, when specimens 
were available. Serum was collected for atypical pathogens 
survey including Mycoplasma pneumoniae, Chlamydophila 
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pneumoniae and Legionella pneumophila antibody mea-
surements: Acute M. pneumoniae, C. pneumoniae and/or 
L. pneumophila infection was diagnosed if the patient had a 
signiﬁ  cant antibody response to one of the pathogens (IgM 
antibody, a 4-fold increase in IgG antibody titre, a static IgG 
antibody titre four times or more than the cut-off of the as-
say). Besides, Legionella urine antigen was also used for de-
tecting L. pneumophila infection.
Radiological studies
Serial chest X-rays (CXRs) obtained on admission and dur-
ing hospitalization were reviewed by a pulmonologist and 
a radiologist. If a discrepancy existed in the interpretations, 
the CXR was further reviewed by another chest or radiologi-
cal specialist blinded to the results. The predominant radio-
graphic pattern (upper lobe inﬁ  ltrate, multi-lobar inﬁ  ltrates, 
alveolar consolidation, pleural effusion, bronchiectasis, and 
emphysematous change), and the presence of cavities were 
recorded.
Statistical analysis
Data was expressed either as percentage for the group (cat-
egorical variables) or as mean ± SD (continuous variables). 
Continuous variables were compared with use of Student’s t-
test for normally distributed data. Categorical variables were 
compared with use of the χ2 and Fisher’s exact tests. The 
statistical package (SAS version 9.1.3, SAS Institute; Cary, 
NC) was used for all analyses. All P values were 2 sided; P 




Subjects 128 70.3 54 29.7 182 100.0
Age years 48.4 ± 23.0 (20 - 93) 64.0 ± 23.0 (16 - 89) 53.0 ± 24.0 (16 - 93) < 0.0001
< 30 years 44 34.4 10 18.5 54 29.7
30-60 years 43 33.6 5 9.3 48 26.4
> 60 years 41 32.0 39 72.2 80 43.9
Male sex 106 79.2 44 77.3 150 78.7 NS
Indigenes 80 62.5 27 50.0 107 58.8 NS
Origin
Geriatric members 40 31.3 25 46.3 65 35.7 NS
Military conscripts 26 20.3 6 11.1 32 17.6 NS
Civilian 62 48.4 23 42.6 85 46.7 NS
Low socioeconomic 71 55.5 40 74.1 111 61.0 0.0187
Comorbidities
Ever-smoker 64 50.0 30 55.6 94 51.6 NS
COPD 28 21.9 13 24.1 41 22.5 NS
Recurrent PTB 27 21.1 8 14.8 35 19.2 NS
Alcoholism 44 34.4 17 31.5 61 33.5 NS
HCV 5 3.9 5 9.3 10 5.5 NS
Cirrhosis 15 11.7 9 16.7 24 13.2 NS
Renal insufﬁ  ciency 13 10.2 15 27.8 28 15.4 0.0041
Diabetes 13 10.2 7 13.0 20 11.0 NS
Malignancy 5 3.9 6 11.1 11 6.0 NS
HIV 0 0 1 1.9 1 0.5 NS
Data are presented as mean ± SD (range) unless otherwise indicated. NS: non-signiﬁ  cant; PTB: pulmonary tuberculosis; COPD: 
chronic obstructive pulmonary disease; HCV: hepatitis C virus; HIV: human immunodeﬁ  ciency virus. P-value for comparisons 
between PTB and dual infections.
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Table 2. Symptoms, Laboratory and Radiographic Characteristics of Active PTB Patients
Data are presented as mean ± SD and N (%) unless otherwise indicated. NS: non-signiﬁ  cant; PTB: pulmonary tuberculosis; 
WBC: white blood cell counts; Na: sodium; K: potassium; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: 
alanine aminotransaminase; γ-GT: gamma glutamyl transpeptidase.
Control Subject Total
P-value
N% N% N %
Clinical symptoms
Fever 68 53.1 23 42.6 91 50.0 NS
Cough/sputum 100 78.1 49 90.7 149 81.9 0.0436
Hemoptysis 13 10.2 7 13.0 20 11.0 NS
Chest pain 18 14.1 6 11.1 24 13.2 NS
Weight loss 24 18.8 7 13.0 31 17.0 NS
Laboratory characteristics
WBC (103/μL) 9.0 ± 4.3 11.7 ± 5.2 9.8 ± 4.7 0.0005
    Hemoglobin (g/dL) 12.3 ± 1.8 11.8 ± 2.1 12.2 ± 1.9 NS
Platelet (103/μL) 302.1 ± 134.5 259.0 ± 108.5 288.7 ± 128.2 0.0400
Neutrophil (%) 74.0 ± 11.3 78.4 ± 13.7 75.4 ± 12.2 0.0318
Lymphocyte (%) 16.7 ± 8.8 12.6 ± 8.3 15.4 ± 8.8 0.0059
Na (mmol/L) 134.7 ± 5.2 133.2 ± 7.6 134.3 ± 6.0 NS
K (mmol/L) 4.0 ± 0.6 3.9 ± 0.7 4.0 ± 0.6 NS
BUN (mg/dL) 15.0 ± 8.8 25.3 ± 21.4 18.1 ± 14.6 0.0014
Creatinine (mg/dL) 1.0 ± 0.6 1.2 ± 0.8 1.1 ± 0.6 NS
AST (U/L) 39.0 ± 37.1 52.2 ± 61.5 42.7 ± 45.5 NS
ALT (U/L) 29.1 ± 28.0 50.7 ± 121.0 34.9 ± 67.2 NS
Total bilirubin (mg/dL) 1.1 ± 1.3 1.1 ± 0.9 1.1 ± 1.2 NS
γ-GT (U/L) 65.5 ± 103.2 91.2 ± 174.1 72.3 ± 125.7 NS
Alkaline phosphatase (U/L) 93.7 ± 48.3 90.0 ± 47.2 92.3 ± 47.7 NS
Cholesterol (mg/dL) 128.1 ± 39.1 121.1 ± 53.4 126.1 ± 43.5 NS
Triglyceride (mg/dL) 89.6 ± 57.9 85.7 ± 59.6 88.4 ± 58.2 NS
Albumin (mg/dL) 3.1 ± 0.7 2.8 ± 0.8 3.0 ± 0.8 0.0091
Radiographic characteristics
Upper lobe inﬁ  ltrate 70 54.7 18 33.3 88 48.4 0.0085
Multi- lobar inﬁ  ltrates 11 8.6 12 22.2 23 12.6 0.0115
Alveolar consolidation 33 25.8 26 48.2 59 32.4 0.0032
Pleural effusion 24 18.8 8 14.8 32 17.6 NS
Cavitary lesion 13 10.2 3 5.6 16 8.8 NS
Bronchiectasis 8 6.3 3 5.6 11 6.0 NS
Emphysema 20 15.6 4 7.4 24 13.2 NS
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Table 3. Sputum AFB, Delayed Diagnosis of PTB and In-hospital Outcomes of Both Groups
Figure 1. In-hospital survival curves of subjects (black line) and controls (red line) using Kaplan-Meier. P (log 
rank test) < 0.005.
Control Subject Total
P-value
N% N% N %
Positive sputum AFB 61 47.7 28 51.9 92 50.5 NS
Delayed diagnosis of PTB 37 28.8 25 46.3 62 34.1 0.0271
In-hospital outcomes 0.0436
Nosocomial pneumonia 10 7.8 12 22.2 22 12.1 0.0064
Acute respiratory failure 11 8.6 17 31.5 28 15.4 < 0.0001
Septic shock 4 3.1 8 14.8 12 6.6 0.0069
Mortality 5 3.9 14 25.9 19 10.4 < 0.0001
< 0.05 was considered signiﬁ  cant. Survival curves were ob-
tained using Kaplan-Meier method and compared with use 
of log rank tests.
Results
Patient characteristics
A total of 182 patients with conﬁ  rmed PTB accounted for 
4.6% of all patients with community-acquired respiratory 
infections admitted to the hospital within the study period. 
The baseline characteristics of patients with isolated PTB 
(controls) and dual infections (subjects) were shown in Table 
1. Of them, 54 (29.7%) had concurrent non-mycobacterial 
respiratory infections at admission. The median age of the 
182 patients who enrolled in the study was 53 years (range 
16 - 93) and 78.7% (150/182) of the patients were male. The 
subjects exhibited an older median age than controls (64.0 
years versus 48.4 years, P < 0.0001). Indigenes accounted 
for more than half of hospital admissions (58.8%). No sta-
tistically signiﬁ  cant differences were observed between the 
two groups with respect to their origins: geriatric members 
(31.3% versus 46.3%), military staff and conscripts (20.3% 
versus 11.1%) and civilian (48.4% versus 42.6%). Over six-
ty percent of active PTB patients were classiﬁ  ed in a low 
Data are presented as N (%) unless otherwise stated. NS: non-signiﬁ  cant; AFB: acid-fast stain; PTB: pulmonary tuberculosis.
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socioeconomic status, particularly in subjects (55.5% ver-
sus 74.1%, P = 0.0187). Comorbid illness was common in 
patients with active PTB, with 51.6% being ever-smokers, 
22.5% having COPD, 19.2% having recurrent PTB, 33.5% 
being alcoholism, 5.5% having hepatitis C virus (HCV) in-
fection, 13.2% having liver cirrhosis, 11.0% having type 
2 diabetes and 6% having malignancy.  Only one patient 
(0.5%) was identiﬁ  ed as having HIV.
Disease presentations
Table 2 illustrates clinical symptoms, laboratory, and radio-
graphic characteristics of patients with active PTB on admis-
sion. Cough and sputum production were the most common 
symptoms (81.9%) and there was a statistically signiﬁ  cant 
difference between these two groups (78.1% versus 90.7%, 
P = 0.0436). In laboratory investigations, signiﬁ  cantly higher 
white blood cell counts (WBC) (11.7 ± 5.2 x 103/μL ver-
sus 9.0 ± 4.3 x 103/μL, P = 0.0005) with left shift and lower 
platelet counts (259.0 ± 108.5 x 103/μL versus 302.1 ± 134.5 
x 103/μL, P = 0.0400) were seen in subjects on admission 
compared with controls. A number of biochemical param-
eters of serum showed no statistically signiﬁ  cant differences 
between the two groups including electrolytes: sodium (Na) 
and potassium (K), creatinine, hepatobiliary proﬁ  les: aspar-
tate aminotransferase (AST), alanine aminotransaminase 
(ALT), total bilirubin, gamma glutamyl transpeptidase (γ-
GT), and alkaline phosphatase, as well as lipid proﬁ  les: total 
cholesterol and triglyceride. There were statistically signiﬁ  -
cant differences between the two groups with respect to the 
serum BUN (15.0 ± 8.8 mg/dL versus 25.3 ± 21.4 mg/dL, P 
= 0.0014) and albumin (3.1 ± 0.7 mg/dL versus 2.8 ± 0.8 mg/
dL, P = 0.0091).
As to radiological presentations on admission, classi-
cal upper lobe inﬁ  ltrate was more prominent in controls, but 
alveolar consolidation and multi-lobar inﬁ  ltrative patterns 
were more extensive in subjects. Pleural effusion, cavitation, 
bronchiectasis and emphysematous change were equivalent 
between these two groups.
Acid-fast stain, delayed diagnosis of active PTB and in-
hospital outcomes
As shown in Table 3, the subjects had a higher incidence in 
the delayed diagnosis of active PTB than controls (46.3% 
versus 28.8%, P = 0.0271) despite they had similar rates of 
positive AFB. Statistically signiﬁ  cant differences existed be-
tween the two groups with respect to in-hospital outcomes 
including nosocomial pneumonia (7.8% versus 22.2%, P 
= 0.0064), acute respiratory failure (8.6% versus 15.4%, P 
< 0.0001), septic shock (3.1% versus 14.8%, P = 0.0069), 
and mortality (3.9% versus 25.9%, P < 0.0001). The mean 
in-hospital survival of the subjects who died was 31.6 days 
(range 11 - 59) with 50% of them dying within the ﬁ  rst 21 
Table 4. Bacterial Species and the Associated Number of the Sub-
jects
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days and 75% of them dying within the ﬁ  rst 48 days (Fig. 1).
Microbiological characteristics
In mycobacterial investigations, only one subject had miliary 
TB, which was proved by liver biopsy and another two had 
multi-drug resistant TB (MDR-TB) during the period of anti-
tuberculous treatment in the group of dual infections (data 
not shown). Table 4 demonstrated the bacterial species and 
the associated number of the subjects. A total of 20 subjects 
with atypical bacterial infections: 12 having M. pneumoni-
ae, 6 having L. pneumophila, and 2 having C. pneumoniae. 
There were 13 subjects with Gram-positive bacterial infec-
tions: 6 having Steptococcus pneumoniae, 6 having Staphy-
lococcus aureus, and 1 having Enterococcus species. Addi-
tionally, 33 subjects with Gram-negative bacterial infections 
were reported: 11 having Klebsiella pneumoniae, 6 having 
Haemophilus inﬂ  uenzae, 4 having Pseudomonas aerugino-
sa, 4 having Escherichia coli, 3 having Proteus mirabilis, 3 
having Stenotrophomonas maltophilia and 2 having Entero-
bacter. Only 20 subjects meet criteria for deﬁ  nite dual respi-
ratory infections. Table 5 displayed an equivalent mortality 
rate of the subjects with different kinds of bacterial infec-
tions (atypical versus Gram-positive versus Gram-negative: 
30.0% versus 30.8% versus 30.2%). However, we noticed 
that the subjects with poly-bacterial infections had a high-
er mortality rate than those with mono-bacterial infections 
(43.5% versus 12.9%, P = 0.0147).
Discussion
  
Based on the investigations in Hualien by Taiwan’s Centers 
for Disease Control (CDC) over the past 8 years, 80% of all 
tuberculous patients were PTB and 70% of the new cases 
were male. At the time of diagnosis, the mean age for pa-
tients ranged from 52 to 55 year-old and almost 50% were 
elderly, or those who were more than 65 years in age. Ethnic 
minorities (indigenes) had higher incidence than the ethnic 
majorities [2, 13]. Military conscripts have also shown high 
prevalence of TB on previous reports [14, 15]. In our study, 
recognized PTB patients of the hospital shared similar de-
mographic characteristics with those in the general survey of 
Hualien. Smoking, alcoholism, and chronic organic diseases 
were most common among these people. On the contrary, 
HIV infections were encountered in only 0.5% of patients 
with TB and the prevalence rate was close to the nationwide 
statistic [13]. The main ﬁ  ndings were that people with older 
age and low socioeconomic status were predisposed to con-
comitant active PTB and non-myobacterial respiratory infec-
tions. As we know, aging itself had the natural history of pro-
gressive immune dysregulation such as a reduction in CD8+ 
T cells and a decline in T cell proliferation [16, 17]. These 
factors accounted for not only the increased rates of TB, but 
also non-mycobacterial infections in the elderly. Second, 
low socioeconomic status has been a well-known risk of M. 
tuberculosis infection, but such a connection was absent for 
other non-myobacterial pathogens [18, 19]. The reason for 
that was probably because aged persons represented were of 
low socioeconomic status in Hualien; with the elderly pro-
portionally increasing in number, low socioeconomic status 
reﬂ  ected a higher rate in the group of dual PTB and bacterial 
infections than in control.
It was not surprising that patients with dual infections 
presented more frequent symptoms of cough and sputum 
production, leukocytosis with left shift, and less platelet 
counts that were caused by the host immune response to the 
external stimuli of pathogenic bacteria. Regarding to the 
laboratory ﬁ  nings of renal insufﬁ  ciency with elevating BUN 
level and lower serum albumin in subjects, these implied 
Survivors Deceased Total
P-value
N% N% N %
Bacteriological classiﬁ  cations NS
Atypical bacteria 14 70.0 6 30.0 20 30.3
Gram-positive bacteri 9 69.2 4 30.8 13 19.7
Gram-negative bacteria 23 69.7 10 30.2 33 50.0
Number of non-TB bacterial infections 0.0147
Poly-bacterial infection 13 56.5 10 43.5 23 42.6
Mono-bacterial infection 27 87.1 4 12.9 31 57.4
Table 5. Microbiological Charateristics and the Prognosis in Patients With Dual Infections
Data are presented as N (%) unless otherwise stated. NS: non-signiﬁ  cant; TB: tuberculosis.
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the underlying malnutrition, status of volume depletion, and 
advanced illness [20-21]. With the accumulated evidence, 
malnourished people with impaired immunity were vulner-
able to M. tuberculosis and other microbial infections [22, 
23]. Recently, numerous studies showed that a lower serum 
albumin level obtained on admission could be used as an 
independent risk of in-hospital death among patients with 
active TB [24, 25]. With respect to the radiological appear-
ances at admission, patterns of multi-lobar inﬁ  ltrates and al-
veolar consolidation rather than classical upper lobe lesions 
of tuberculosis were mostly seen in subjects. It correlated 
well with the radiological presentations of PTB in elderly 
and superimposed inﬂ  ammatory process conferred by non-
mycobacterial infections [26, 27]. These unexpected expres-
sions of double pulmonary infections clinically masked ac-
tive PTB and further delayed the diagnosis of tuberculosis 
until the cultures were available. As compared to the two 
groups with active PTB, more in-hospital morbidity and 
mortality rates were observed in the group of dual infec-
tions. A number of variables other than lower serum albumin 
level mentioned above have been acknowledged as risks of 
adverse outcomes in PTB patients, including older age, more 
extensive inﬁ  ltrative and consolidation patterns on chest ra-
diographs, and delayed anti-tuberculous treatment [28-29]. 
Obviously, more risks imposed on patients with dual infec-
tions could lead to poor clinical outcomes.
In analyzing the bacteriologic characteristics, dual PTB 
and bacterial respiratory infections were remarkable (54/182, 
29.7%) in this non-HIV epidemic area. This may reﬂ  ect the 
age, general health and socioeconomic status of the patients 
as well as the criterion we used for non-mycobacterial respi-
ratory tract disease (20/182, 11.0% for deﬁ  nite diagnosis). 
Whether a strict selection for subjects was taken or not, an 
association between atypical pathogens and environment 
was present. We found the relatively young age of military 
conscripts and students were chief sufferers of M. pneumoni-
ae and elderly geriatrics accounted for C. pneumoniae and 
L. pneumophila. The other kinds of bacteria species were 
mainly dependent on the age and the related comorbidities of 
patients regardless of the place. The elderly with limited ac-
tivity were prone to have Gram-positive and Gram-negative 
bacterial infections. The retrospective analysis of these 54 
case patients found an in-hospital mortality rate of 25.9%. 
There had some reports describing such a high mortality rate 
among HIV patients with active TB and speciﬁ  c bacteria like 
L. pneumophila and S. pneumoniae infections [30, 31]. In 
addition, hospital-acquired gram-negative bacterial pneumo-
nia has also been regarded as a poor prognostic factor for 
patients with TB [32]. However, this correlation was not 
appropriate for our PTB patients with community-acquired 
bacterial respiratory infections due to the limited case num-
bers, less drug-resistant strains, and no difference in mor-
tality rate regarding to bacteriological classiﬁ  cations. In our 
observations, poly-bacterial infections occurred in 42.6% of 
subjects and had a signiﬁ  cantly higher mortality rate than 
that of mono-bacterial infection. Although poly-bacterial re-
spiratory infections could result from benign microbial col-
onization leading to the incidence rate overestimated, they 
were pathogenetically associated with poor oral hygiene, 
aspirations, diabetes mellitus, speciﬁ  c viral co-infection and 
extensive immunosuppression [33-35]. Under these circum-
stances, patients presented more severe illness on admission, 
which may cause the following high morbidities and mor-
talities in hospital.
In conclusion, concomitant TB and bacterial respiratory 
infections were prevalent in Hualien, Taiwan. The majority 
of patients were elderly with lower socioeconomic status. 
Comobidities were common in this population. Patients pre-
sented more symptoms of cough with sputum production, 
and laboratory ﬁ  ndings of leukocytosis with left shift, throm-
bocytopenia, renal insufﬁ  ciency and lower serum albumin 
level. Besides, multi-lobar inﬁ  ltrates and alveolar consoli-
dations patterns were predominant in chest radiograph at 
admission. Delayed diagnosis in active PTB as well as in-
creased rates of in-hospital morbidity and mortality related 
to poly-bacterial infections were observed.
The main limitation was that dual infections could not 
be convinced depending on either presumptive deﬁ  nition or 
deﬁ  nite criteria. We may overestimate the “false subjects” 
with benign bacterial colonization by loosely presumptive 
deﬁ  nition and underestimate the “true subjects” with posi-
tive AFB receiving successful combined antibiotics and 
anti-tuberculous treatment by deﬁ  nite criteria. Nevertheless, 
the study clariﬁ  ed the factors contributing to dual TB and 
bacterial respiratory infections and the associated outcomes 
in Hualien, Taiwan. A better geriatric health care policy to 
reduce the overall mortality of PTB in a non-HIV associated 
TB prevalent area was needed and should be worked out im-
mediately.
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